Markus Maeurer is a Medical Doctor with a Ph.D. from the Johannes Guttenberg University of Mainz (Mainz, Germany). He has been working in several fields, with the main emphasis on tuberculosis development of novel treatments and/or prevention, host–pathogen interactions, immunotherapy, and the development of new antitumoral treatments. During his career, he has worked in several institutions, including Johannes Guttenberg University of Mainz (Mainz, Germany), University of Pittsburgh (Pittsburgh, USA), Karolinska Institute (Stockholm, Sweden), and, currently, as the Head of the ImmunoSurgery/ImmunoTherapy Laboratory at the Champalimaud Center for the Unknown (Lisbon, Portugal). He has over 2 decades of experience in the immunology field and is an expert in the use of
immunotherapy to develop new antitumoral treatments.
Research Keywords & Expertise
Cytokines
Immunotherapy
t-cells
Biological therapy
PDAC
tme
neoantigen
Tumor antigens
Tumor-infiltrating lym...
Immunosurgery
T-cell receptor (TCR)
Tumor mutanome
Short Biography
Markus Maeurer is a Medical Doctor with a Ph.D. from the Johannes Guttenberg University of Mainz (Mainz, Germany). He has been working in several fields, with the main emphasis on tuberculosis development of novel treatments and/or prevention, host–pathogen interactions, immunotherapy, and the development of new antitumoral treatments. During his career, he has worked in several institutions, including Johannes Guttenberg University of Mainz (Mainz, Germany), University of Pittsburgh (Pittsburgh, USA), Karolinska Institute (Stockholm, Sweden), and, currently, as the Head of the ImmunoSurgery/ImmunoTherapy Laboratory at the Champalimaud Center for the Unknown (Lisbon, Portugal). He has over 2 decades of experience in the immunology field and is an expert in the use of
immunotherapy to develop new antitumoral treatments.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
